Jinhui Guo

573 total citations
23 papers, 307 citations indexed

About

Jinhui Guo is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, Jinhui Guo has authored 23 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Epidemiology. Recurrent topics in Jinhui Guo's work include Ubiquitin and proteasome pathways (8 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (4 papers). Jinhui Guo is often cited by papers focused on Ubiquitin and proteasome pathways (8 papers), RNA modifications and cancer (5 papers) and Cancer-related molecular mechanisms research (4 papers). Jinhui Guo collaborates with scholars based in China, Germany and Belgium. Jinhui Guo's co-authors include Qiuran Xu, Jie Zhao, Dongsheng Huang, Junjun Zhao, Dong‐Sheng Huang, Li Chang, Xin Zhang, Qiliang Lu, Yu Cao and Ting Gong and has published in prestigious journals such as Biochemical and Biophysical Research Communications, The Journal of Physical Chemistry C and Frontiers in Immunology.

In The Last Decade

Jinhui Guo

22 papers receiving 306 citations

Peers

Jinhui Guo

ONCOL

EPIDE

PRM

Manal L. Louka Egypt

Eman Khairy Egypt

Xiao-Yi Lu China

Charles A. Reidy United States

Jin Zou China

Stamatis Theocharis Greece

Valentina Gambino Italy

Stéphane Pierre France

Yoon Young Cho South Korea

Fengting Su China

Manal L. Louka Egypt

Jinhui Guo

173 ×0.9

119 ×1.4

45 ×0.8

ONCOL

33 ×0.9

EPIDE

24 ×0.8

PRM

Citations per year, relative to Jinhui Guo Jinhui Guo (= 1×) peers Manal L. Louka

Countries citing papers authored by Jinhui Guo

Since Specialization

Citations

This map shows the geographic impact of Jinhui Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinhui Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinhui Guo more than expected).

Fields of papers citing papers by Jinhui Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinhui Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinhui Guo. The network helps show where Jinhui Guo may publish in the future.

Co-authorship network of co-authors of Jinhui Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Jinhui Guo. A scholar is included among the top collaborators of Jinhui Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinhui Guo. Jinhui Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Qingsong, Yuanyuan Qiu, Jinhui Guo, et al.. (2024). USP40 promotes hepatocellular carcinoma cell proliferation, migration and stemness by deubiquitinating and stabilizing Claudin1. Biology Direct. 19(1). 13–13. 5 indexed citations

Wu, Yuchen, Dongdong Wang, Jie Zhao, et al.. (2024). NRAV promoted the malignant progression of gastric cancer. Gene. 937. 149134–149134.

Zhao, Jie, Qiang Huo, Ji Zhang, et al.. (2024). UCHL3 promotes hepatocellular carcinoma progression by stabilizing EEF1A1 through deubiquitination. Biology Direct. 19(1). 53–53. 6 indexed citations

Guo, Jinhui & Jie Zhao. (2023). USP22-JMJD8 axis promotes Lenvatinib resistance in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(1). 119617–119617. 4 indexed citations

Guo, Jinhui, Jie Zhao, Qiuran Xu, & Dongsheng Huang. (2023). MEX3C as a potential target for hepatocellular carcinoma drug and immunity: combined therapy with Lenvatinib. BMC Cancer. 23(1). 967–967. 7 indexed citations

Fu, Wenbin, Jinhui Guo, Qiliang Lu, et al.. (2023). Hypoxia-induced UBE2K promotes the malignant progression of HCC. Pathology - Research and Practice. 245. 154422–154422. 3 indexed citations

Braeckevelt, Tom, Jinhui Guo, Bapi Pradhan, et al.. (2023). Additivity of Atomic Strain Fields as a Tool to Strain-Engineering Phase-Stabilized CsPbI₃ Perovskites. The Journal of Physical Chemistry C. 127(48). 23400–23411. 3 indexed citations

Guo, Jinhui, et al.. (2022). Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms. Frontiers in Immunology. 13. 918314–918314. 49 indexed citations

Guo, Jinhui, Jie Zhao, Litao Sun, & Yang Chen. (2022). Role of ubiquitin specific proteases in the immune microenvironment of prostate cancer: A new direction. Frontiers in Oncology. 12. 955718–955718. 9 indexed citations

10.

Zhao, Jie, Jinhui Guo, Yanan Wang, et al.. (2022). Research Progress of DUB Enzyme in Hepatocellular Carcinoma. Frontiers in Oncology. 12. 920287–920287. 15 indexed citations

11.

Zeng, Zhi, Zhan Shi, Liu Yang, et al.. (2021). HIF-1α-activated TM4SF1-AS1 promotes the proliferation, migration, and invasion of hepatocellular carcinoma cells by enhancing TM4SF1 expression. Biochemical and Biophysical Research Communications. 566. 80–86. 15 indexed citations

12.

Liu, Yang, Runkun Liu, Junjun Zhao, et al.. (2021). LncRNA TMEM220-AS1 suppresses hepatocellular carcinoma cell proliferation and invasion by regulating the TMEM220/β-catenin axis. Journal of Cancer. 12(22). 6805–6813. 5 indexed citations

13.

Guo, Jinhui & Li-Fang Yu. (2021). CircWEE1/miR-138 axis promotes the malignant progression of glioma by regulating SIRT1. Translational Cancer Research. 10(4). 1863–1873. 6 indexed citations

14.

Guo, Jinhui, et al.. (2021). Association between glycemic control assessed by continuous glucose monitoring and stroke in patients with atrial fibrillation and diabetes mellitus. Annals of Palliative Medicine. 10(8). 9157–9164. 3 indexed citations

15.

Guo, Jinhui, et al.. (2018). Knockout of CNR1 prevents metabolic stress-induced cardiac injury through improving insulin resistance (IR) injury and endoplasmic reticulum (ER) stress by promoting AMPK-alpha activation. Biochemical and Biophysical Research Communications. 503(2). 744–751. 10 indexed citations

16.

Wu, You, et al.. (2017). Long noncoding RNA eosinophil granule ontogeny transcript inhibits cell proliferation and migration and promotes cell apoptosis in human glioma. Experimental and Therapeutic Medicine. 14(4). 3817–3823. 15 indexed citations

17.

Wang, Qingjiang, et al.. (2015). Super-compact treatment with a high dose of moxifloxacin in patients with drug-resistant tuberculosis and its resistance mechanisms. Experimental and Therapeutic Medicine. 9(4). 1314–1318. 6 indexed citations

18.

Niu, Panpan, Yu Cao, Ting Gong, et al.. (2014). Hypermethylation of DDAH2 promoter contributes to the dysfunction of endothelial progenitor cells in coronary artery disease patients. Journal of Translational Medicine. 12(1). 170–170. 25 indexed citations

19.

Guo, Jinhui, et al.. (2014). Ginsenoside compound K promotes β-amyloid peptide clearance in primary astrocytes via autophagy enhancement. Experimental and Therapeutic Medicine. 8(4). 1271–1274. 32 indexed citations

20.

Tang, Xiaojiang, Xiaojun Yang, Jinhui Guo, et al.. (2010). Mechanism underlying hypokalemia induced by trimethyltin chloride: Inhibition of H+/K+-ATPase in renal intercalated cells. Toxicology. 271(1-2). 45–50. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact